Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma.
ETS proteins are a family of transcription factors that play important roles in the development of cancer. The Ewing's sarcoma EWS/ETS fusion oncoproteins control a number of cancer-relevant phenotypes in that disease. We recently demonstrated that EWS/FLI, the most common EWS/ETS fusion in Ewing's sarcoma, regulates a portion of its target genes, including the critical target NR0B1, via GGAA-containing microsatellites in their promoters. Given the unusual nature of microsatellites as EWS/FLI response elements, we sought to elucidate the mechanism of EWS/FLI activity at these sites. We found that the ability to bind GGAA microsatellites is shared by multiple ETS family members from distinct phylogenetic subfamilies. Importantly, however, only EWS/ETS-containing fusions are capable of mediating transcriptional activation via these elements, highlighting a neomorphic function of the Ewing's sarcoma fusion proteins. Additional analysis revealed that the GGAA microsatellite binds EWS/FLI with an affinity that is 2 to 3 orders of magnitude lower than previously identified high-affinity consensus/redundant binding sites. The stoichiometry of this interaction is 2 protein molecules for each DNA molecule, suggesting that EWS/FLI binds these elements as a homodimer. The isolated FLI ETS domain bound microsatellite sequences in a nearly identical fashion to full-length EWS/FLI, thus indicating that residues required for homodimeric binding are localized to the ETS domain. These data suggest a new paradigm for an ETS family member binding to DNA at cancer-relevant genetic loci and highlight emergent properties of EWS/FLI that are required for the development of Ewing's sarcoma.
Gangwal
Kunal
K
Department of Oncological Sciences, University of Utah School of Medicine, and Center for Children's Cancer Research, Huntsman Cancer Institute, Salt Lake City, Utah.
Close
Devin
D
Enriquez
Camille A
CA
Hill
Christopher P
CP
Lessnick
Stephen L
SL
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5752-6
8516324
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10149-54
18626011
Mol Cell Biol. 1994 May;14(5):3230-41
8164678
Nature. 1992 Sep 10;359(6391):162-5
1522903
Cancer Res. 2006 Oct 15;66(20):9937-47
17047056
J Biol Chem. 2000 Sep 15;275(37):28363-70
10867009
Nature. 1996 Nov 28;384(6607):322
8934514
Oncogene. 1993 Aug;8(8):2167-73
8336942
Oncogene. 2009 Nov 19;28(46):4126-32
19718047
Methods Cell Biol. 2008;84:243-62
17964934
Genes Dev. 1989 May;3(5):606-11
2744457
Cancer Cell. 2002 May;1(4):393-401
12086853
Cell Cycle. 2006 Dec;5(23):2753-9
17172842
J Bacteriol. 2005 Jul;187(14):5008-12
15995218
Oncogene. 1997 Mar 13;14(10):1159-64
9121764
Cancer Genet Cytogenet. 1988 Jun;32(2):229-38
3163261
Nat Genet. 1994 Feb;6(2):146-51
8162068
PLoS One. 2009;4(3):e4932
19305498
Science. 2005 Jul 1;309(5731):142-5
15994560
Oncogene. 1995 Mar 16;10(6):1229-34
7700648
Oncogene. 2003 Oct 9;22(44):6819-29
14534527
Nat Rev Mol Cell Biol. 2001 Nov;2(11):827-37
11715049
J Biol Chem. 1996 Sep 20;271(38):23329-37
8798534
Biochem Biophys Res Commun. 1996 Feb 15;219(2):608-12
8605035
Mol Cancer Res. 2006 Nov;4(11):851-9
17114343
Cancer Res. 2009 Dec 1;69(23):9047-55
19920188
Genes Dev. 1992 Jun;6(6):975-90
1592264
Genes Chromosomes Cancer. 1996 Feb;15(2):115-21
8834175
Mol Cell Biol. 1993 Dec;13(12):7393-8
8246959
Mol Cell Biol. 2000 Aug;20(15):5643-52
10891501
EMBO J. 2008 Jul 23;27(14):2006-17
18566588
J Mol Biol. 2008 Oct 17;382(4):1014-30
18692067
Brief Funct Genomic Proteomic. 2006 Mar;5(1):8-14
16769671
Oncogene. 2008 Oct 9;27(46):6034-43
18591936
Cancer Cell. 2006 May;9(5):405-16
16697960
Oncogene. 1999 Feb 11;18(6):1351-9
10022817
Genes Dev. 2007 Aug 1;21(15):1882-94
17652178
Cell Cycle. 2008 Oct;7(20):3127-32
18927503
Cell Res. 2007 Apr;17(4):286-8
17426699
Cell Cycle. 2006 Sep;5(18):2049-53
16969112
Eur J Cancer. 2005 Nov;41(16):2462-78
16213704
J Biol Chem. 1994 Jul 8;269(27):18216-22
7517940
PLoS Genet. 2009 Dec;5(12):e1000778
20019798
Mol Cell. 2001 Dec;8(6):1267-76
11779502
Oncogene. 1995 Feb 2;10(3):423-31
7845667